Legence Corp. (LGN) Stock Analysis and Metrics

Legence

NASDAQ: LGN

$71.89 ▲ +1.49 (+2.12%)

At close: Jul 8, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap4.75 Bn

P/E-64.92

P/S1.86

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)829.09 Mn

Revenue Growth (1y) (Qtr)34.55

Add ratio to table…

About

Legence is a leading provider of engineering, installation and maintenance services for mission critical systems in buildings. The company focuses on high growth sectors such as technology, life sciences, healthcare and education, delivering integrated mechanical, electrical and plumbing (MEP) solutions that lower total cost, reduce change orders and accelerate project timelines for clients.

Legence generates revenue from engineering and consulting services as well as installation and maintenance services. In 2025, approximately 40% of its revenue came from new building projects and 60% from retrofits, upgrades and maintenance of existing facilities. The company reported total revenue of $2.55 billion for the year ended December 31, 2025 and a backlog of $3.7 billion as of the same date, representing a 49% increase year over year. Revenue by end market showed that data centers and technology accounted for 42.7%, life sciences and healthcare for 18.0%, education for 16.8%, mixed use for 4.6%, state and local government for 4.2% and other industries for 13.7%.

The company operates through the following segments: Engineering & Consulting and Installation & Maintenance.

• Engineering & Consulting: This segment designs HVAC and other MEP systems, develops strategies to reduce energy usage and improve building sustainability, and provides program and project management services, with approximately 59% of its 2025 revenue from Engineering & Design and 41% from Program & Project Management.

• Installation & Maintenance: This segment fabricates and installs HVAC, process piping and other MEP systems in new and existing buildings and provides preventative and corrective maintenance services, with approximately 82% of its 2025 revenue from Installation & Fabrication and 18% from Maintenance & Service.

Legence competes with national, regional and local firms in both its engineering and installation businesses. National competitors for the Engineering & Consulting segment include Affiliated Engineers Inc., Stantec Inc. and WSP Global Inc., while the Installation & Maintenance segment faces competition from Comfort Systems USA Inc., ACCO Engineered Systems Inc. and Southland Industries Inc., and the company’s advantage lies in offering a full suite of engineering, consulting, installation and maintenance services that smaller rivals often lack.

Legence serves approximately 20,000 clients ranging from technology and industrial firms to public sector institutions such as hospitals, schools and universities. The company maintains long term relationships, with an average tenure of 23 years for its top ten clients and several relationships exceeding 40 years. Its customer base spans data centers, life sciences, healthcare, semiconductors, manufacturing, and education sectors.

Investment Thesis

▲ Bull case

Legence is positioned to capitalize on a structural shift in data center demand that extends well beyond cyclical trends, with management confirming fabrication orders now visible through 2028, indicating multi-year CapEx commitments from hyperscalers and colocators that are not fully reflected in current guidance. This long-duration backlog, combined with the company’s ability to pull forward revenue through accelerated project execution and prepayment terms on custom fab work, creates a self-reinforcing cycle of improved working capital and free cash flow conversion that exceeds 85% of adjusted EBITDA—a metric management did not emphasize but which signals operational efficiency gains that are sustainable as scale increases. The integration of Bowers has not only expanded geographic reach into the DC Virginia corridor but also diversified the customer base toward higher-quality, long-term contracts with hyperscalers, reducing reliance on volatile enterprise IT spending and creating a more resilient revenue stream that is less sensitive to quarterly fluctuations in book-to-bill ratios. Furthermore, the migration of the Engineering & Consulting segment toward high-tech and semiconductor clients is generating untapped cross-selling opportunities that management acknowledged as a “big focus internally” but did not quantify, suggesting potential for incremental revenue growth from existing relationships that could uplift segment margins over time as the mix shifts back toward higher-margin engineering and design work. With net leverage already down to 1.8x from 2.9x nine months prior and free cash flow exceeding $100 million in Q1 alone, Legence has the financial flexibility to pursue bolt-on acquisitions in adjacent markets like life sciences and healthcare—where RFQ activity is rebounding post-COVID overbuild—without compromising its disciplined M&A approach, thereby creating optionality for future growth that the market is underestimating given the current valuation.
The company’s fabrication capacity of 1.3 million square feet is currently underutilized relative to pipeline demand, with management noting they have “room to meet additional demand” and are leveraging learning curve effects, automation, and extended shifts to increase throughput—implying that organic growth in the Installation & Maintenance segment could accelerate beyond the reported 57% year-over-year ex-Bowers if capacity constraints are eased through operational improvements rather than requiring immediate CapEx. This operational leverage, combined with improving adjusted SG&A as a percentage of revenue (down to 8% from 12.6%) and expanding adjusted gross margins in Installation & Maintenance (up to 15.9% from 14.3%), suggests that margin expansion is already underway in the core growth segment and is being driven by process efficiency and economies of scale, not just acquisition integration. Management’s expectation that adjusted SG&A as a percentage of revenue will “probably gravitate down” with continued double-digit top-line growth indicates confidence in scalable infrastructure, which, if realized, could push adjusted EBITDA margins toward 13%+ by year-end—well above the current 11.4% and the guided range of 11.5%–11.8% implied by the $470M–$490M EBITDA target on $4.1B–$4.3B revenue. The market is overlooking how these margin improvements, coupled with the structural shift toward higher-margin fabrication and modular OSM work (which Sprau explicitly called accretive to margins), could deliver earnings upside that exceeds current guidance ranges, especially as life sciences and healthcare backlog rebounds with large multi-year projects being booked after a period of softness.

Legence is positioned to capitalize on a structural shift in data center demand that extends well beyond cyclical trends, with management confirming fabrication orders now visible through 2028, indicating multi-year CapEx commitments from hyperscalers and colocators that are not fully reflected in current guidance. This long-duration backlog, combined with the company’s ability to pull forward revenue through accelerated project execution and prepayment terms on custom fab work, creates a self-reinforcing cycle of improved working capital and free cash flow conversion that exceeds 85% of adjusted EBITDA—a metric management did not emphasize but which signals operational efficiency gains that are sustainable as scale increases. The integration of Bowers has not only expanded geographic reach into the DC Virginia corridor but also diversified the customer base toward higher-quality, long-term contracts with hyperscalers, reducing reliance on volatile enterprise IT spending and creating a more resilient revenue stream that is less sensitive to quarterly fluctuations in book-to-bill ratios. Furthermore, the migration of the Engineering & Consulting segment toward high-tech and semiconductor clients is generating untapped cross-selling opportunities that management acknowledged as a “big focus internally” but did not quantify, suggesting potential for incremental revenue growth from existing relationships that could uplift segment margins over time as the mix shifts back toward higher-margin engineering and design work. With net leverage already down to 1.8x from 2.9x nine months prior and free cash flow exceeding $100 million in Q1 alone, Legence has the financial flexibility to pursue bolt-on acquisitions in adjacent markets like life sciences and healthcare—where RFQ activity is rebounding post-COVID overbuild—without compromising its disciplined M&A approach, thereby creating optionality for future growth that the market is underestimating given the current valuation.
The company’s fabrication capacity of 1.3 million square feet is currently underutilized relative to pipeline demand, with management noting they have “room to meet additional demand” and are leveraging learning curve effects, automation, and extended shifts to increase throughput—implying that organic growth in the Installation & Maintenance segment could accelerate beyond the reported 57% year-over-year ex-Bowers if capacity constraints are eased through operational improvements rather than requiring immediate CapEx. This operational leverage, combined with improving adjusted SG&A as a percentage of revenue (down to 8% from 12.6%) and expanding adjusted gross margins in Installation & Maintenance (up to 15.9% from 14.3%), suggests that margin expansion is already underway in the core growth segment and is being driven by process efficiency and economies of scale, not just acquisition integration. Management’s expectation that adjusted SG&A as a percentage of revenue will “probably gravitate down” with continued double-digit top-line growth indicates confidence in scalable infrastructure, which, if realized, could push adjusted EBITDA margins toward 13%+ by year-end—well above the current 11.4% and the guided range of 11.5%–11.8% implied by the $470M–$490M EBITDA target on $4.1B–$4.3B revenue. The market is overlooking how these margin improvements, coupled with the structural shift toward higher-margin fabrication and modular OSM work (which Sprau explicitly called accretive to margins), could deliver earnings upside that exceeds current guidance ranges, especially as life sciences and healthcare backlog rebounds with large multi-year projects being booked after a period of softness.

▼ Bear case

Legence’s reported organic growth of 57% year-over-year in Q1 FY26 is inflated by a soft prior-year base in the Installation & Maintenance segment, particularly in maintenance and service revenue, which grew over 60% year-over-year but still exceeded 20% ex-Bowers due to a “somewhat softer 2025 comparison”—a tacit admission that much of the growth is cyclical rebound rather than sustainable demand acceleration, especially as the company acknowledged that life sciences and healthcare backlog growth is tied to renewed RFQ activity after a period of overbuild, suggesting this segment’s recovery may be temporary and not indicative of new structural demand. Furthermore, the Engineering & Consulting segment’s 14% revenue growth was driven entirely by a 75% surge in low-margin program and project management services, while engineering and design revenues declined 8% due to tough comparables from prior-year solar advisory work—a mix shift that management admitted has permanently pressured segment margins downward, with adjusted gross margin falling to 33.2% from 40.7% and no clear timeline for recovery beyond a vague expectation to remain in the “low- to mid-30s” range, signaling that the company’s higher-margin legacy business is being structurally eroded by strategic pivots toward lower-margin, scale-driven services.
The company’s reliance on prepayments from custom fabrication work to boost working capital and free cash flow conversion introduces significant risk, as this benefit is contingent on maintaining favorable payment terms with hyperscaler clients who may renegotiate contracts as data center CapEx cycles mature or as competition increases in the modular OSM space—yet management offered no discussion of contractual durability or client concentration risks, despite acknowledging that Bowers integration expanded presence with “certain hyperscalers and colocators,” implying potential reliance on a small number of large accounts. Additionally, while Legence raised full-year 2026 revenue and EBITDA guidance, the book-to-bill ratio of 1.2x for Q1 FY26—down sequentially and attributed to timing of large prior-period awards—suggests that underlying order intake may be weakening even as backlog remains elevated due to deferred recognition, a dynamic that could lead to a sharp revenue deceleration in later quarters if new award momentum fails to sustain, especially given that the company admitted it does not “typically forecast a book to bill” and relies on backward-looking backlog metrics that may mask deteriorating forward demand. Finally, the estimated TRA payment of $8–$9 million for 2025 performance, coupled with potential future TRA payments estimated at “high-20 to low-$30 million” for 2026 activity, represents a significant and growing cash outflow that management downplayed as merely affecting the “net difference” by a 15% reduction, but which could consume 20–30% of annual free cash flow and constrain flexibility for future M&A or shareholder returns, a risk that is not adequately reflected in current leverage metrics or guidance assumptions.

Legence’s reported organic growth of 57% year-over-year in Q1 FY26 is inflated by a soft prior-year base in the Installation & Maintenance segment, particularly in maintenance and service revenue, which grew over 60% year-over-year but still exceeded 20% ex-Bowers due to a “somewhat softer 2025 comparison”—a tacit admission that much of the growth is cyclical rebound rather than sustainable demand acceleration, especially as the company acknowledged that life sciences and healthcare backlog growth is tied to renewed RFQ activity after a period of overbuild, suggesting this segment’s recovery may be temporary and not indicative of new structural demand. Furthermore, the Engineering & Consulting segment’s 14% revenue growth was driven entirely by a 75% surge in low-margin program and project management services, while engineering and design revenues declined 8% due to tough comparables from prior-year solar advisory work—a mix shift that management admitted has permanently pressured segment margins downward, with adjusted gross margin falling to 33.2% from 40.7% and no clear timeline for recovery beyond a vague expectation to remain in the “low- to mid-30s” range, signaling that the company’s higher-margin legacy business is being structurally eroded by strategic pivots toward lower-margin, scale-driven services.
The company’s reliance on prepayments from custom fabrication work to boost working capital and free cash flow conversion introduces significant risk, as this benefit is contingent on maintaining favorable payment terms with hyperscaler clients who may renegotiate contracts as data center CapEx cycles mature or as competition increases in the modular OSM space—yet management offered no discussion of contractual durability or client concentration risks, despite acknowledging that Bowers integration expanded presence with “certain hyperscalers and colocators,” implying potential reliance on a small number of large accounts. Additionally, while Legence raised full-year 2026 revenue and EBITDA guidance, the book-to-bill ratio of 1.2x for Q1 FY26—down sequentially and attributed to timing of large prior-period awards—suggests that underlying order intake may be weakening even as backlog remains elevated due to deferred recognition, a dynamic that could lead to a sharp revenue deceleration in later quarters if new award momentum fails to sustain, especially given that the company admitted it does not “typically forecast a book to bill” and relies on backward-looking backlog metrics that may mask deteriorating forward demand. Finally, the estimated TRA payment of $8–$9 million for 2025 performance, coupled with potential future TRA payments estimated at “high-20 to low-$30 million” for 2026 activity, represents a significant and growing cash outflow that management downplayed as merely affecting the “net difference” by a 15% reduction, but which could consume 20–30% of annual free cash flow and constrain flexibility for future M&A or shareholder returns, a risk that is not adequately reflected in current leverage metrics or guidance assumptions.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Engineering & Construction

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	STN	Stantec Inc	7,704.08 Bn	7,675.69	591.81	1.34 Bn
2	PWR	Quanta Services, Inc.	103.60 Bn	92.14	3.44	5.89 Bn
3	MTZ	Mastec Inc	30.47 Bn	63.56	1.99	2.53 Bn
4	STRL	Sterling Infrastructure, Inc.	23.80 Bn	63.82	8.25	0.29 Bn
5	APG	APi Group Corp	18.02 Bn	-67.25	2.20	2.76 Bn
6	J	Jacobs Solutions Inc.	14.73 Bn	-745.61	1.12	4.08 Bn
7	IESC	IES Holdings, Inc.	13.95 Bn	38.52	3.84	0.04 Bn
8	ACM	Aecom	8.61 Bn	-69.12	0.54	2.71 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password